Event Group
Event Groups are part of the Adverse Events Module within the Results Section. They provide a way to organize and summarize adverse event data by grouping related events together.
Each Event Group typically represents a category or class of adverse events and includes statistical information such as the number of participants affected and at risk for different event types: deaths, serious events, and other events.
Event Group path is as follows:
Study -> Results Section -> Adverse Events Module -> Event Group
Event Group
Ignite Creation Date:
2025-12-24 @ 9:07 PM
Ignite Modification Date:
2025-12-25 @ 6:58 PM
NCT ID:
NCT01263704
Group ID:
EG000
Title:
Rituximab Plus Fludarabine and Cyclophosphamide
Description:
Elderly participants with chronic lymphocytic leukemia (CLL) received combination treatment with low-dose fludarabine and cyclophosphamide combined with standard-dose of rituximab for 6 months. Treatment was followed by a follow up period of 36 months.
Deaths Number Affected:
2
Deaths Number At Risk:
None
Serious Number Affected:
19
Serious Number At Risk:
42
Other Number Affected:
41
Other Number At Risk:
42
Study:
NCT01263704
Results Section:
NCT01263704
Adverse Events Module:
NCT01263704